Congress planning in 2024: Pain points and opportunities

Between December 2023 and February 2024, we conducted a two-phase multi-methodology research study, collecting feedback from global pharmaceutical company employees whose job roles involve the planning and delivery of congress.

In this report, we uncover the challenges faced by congress planners working in pharma, what is required to mitigate these challenges, and ultimately, how you can improve the execution of future congress events. We explore key research and findings, such as:

• 88% feel they are ‘up against it’ at congress and attribute these issues to lack of alignment within the organization
• 7% feel equipped to measure the ROI of their congress activity
• 56% described the congress planning process as ‘decentralized’, ‘complicated’, ‘chaotic’ and ‘disorganized’

We dig into how the challenges of congress delivery can be overcome, to unlock the real value.

Download the report below.